Here, we identify that RASSF1 CGI methylation correlates with hippo pathway inactivation and loss of pS127-YAP1 in sporadic malignancies and provide evidence for the association of this methylation with invasive behavior in cancers, such as breast, bladder, and in gliomas. Here, RASSF1 is linked to central nervous system cancer.